HomeCompareEPEM vs JNJ

EPEM vs JNJ: Dividend Comparison 2026

EPEM yields 3.53% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPEM wins by $5.1K in total portfolio value
10 years
EPEM
EPEM
● Live price
3.53%
Share price
$24.24
Annual div
$0.86
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$443.66
Full EPEM calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EPEM vs JNJ

📍 EPEM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEPEMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EPEM + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EPEM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPEM
Annual income on $10K today (after 15% tax)
$300.44/yr
After 10yr DRIP, annual income (after tax)
$377.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $326.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPEM + JNJ for your $10,000?

EPEM: 50%JNJ: 50%
100% JNJ50/50100% EPEM
Portfolio after 10yr
$22.6K
Annual income
$635.72/yr
Blended yield
2.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EPEM
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPEM buys
0
JNJ buys
0
No recent congressional trades found for EPEM or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEPEMJNJ
Forward yield3.53%3.36%
Annual dividend / share$0.86$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.1K$20.0K
Annual income after 10y$443.66$827.78
Total dividends collected$4.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EPEM vs JNJ ($10,000, DRIP)

YearEPEM PortfolioEPEM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,053$353.46$10,676$355.77+$377.00EPEM
2$12,192$365.13$11,407$389.39+$785.00EPEM
3$13,422$376.40$12,198$426.53+$1.2KEPEM
4$14,749$387.26$13,056$467.62+$1.7KEPEM
5$16,179$397.71$13,987$513.12+$2.2KEPEM
6$17,719$407.73$14,998$563.56+$2.7KEPEM
7$19,377$417.33$16,098$619.52+$3.3KEPEM
8$21,160$426.52$17,295$681.69+$3.9KEPEM
9$23,077$435.29$18,599$750.82+$4.5KEPEM
10$25,136$443.66$20,022$827.78+$5.1KEPEM

EPEM vs JNJ: Complete Analysis 2026

EPEMStock

The Harbor Emerging Markets Equity ETF (EPEM) is an actively managed exchange-traded fund that seeks long-term total return. The fund primarily invests in equity securities, principally common stocks, of emerging markets companies. It employs a bottom-up investment process with fundamental and qualitative criteria to select companies that demonstrate discipline, adaptability, and a long-term orientation.

Full EPEM Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EPEM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPEM vs SCHDEPEM vs JEPIEPEM vs OEPEM vs KOEPEM vs MAINEPEM vs ABBVEPEM vs MRKEPEM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.